Synthesis and evaluation of LOX inhibitory activity of 2-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-phenylacetamide derivatives

Ahmad Mohammadi-Farani, Arash Haqiqi, Sahar Jamshidy Navid, Alireza Aliabadi

Abstract


A family of structurally related LOX enzymes present in human cells which catalyse the metabolism of released arachidonic acid from phospholipids by inflammatory stimuli, to biologically active mediators. Mainly, expression of three types of LOXs occurs in cells, which catalyse the insertion of molecular oxygen into the molecule of arachidonic acid at carbon 5, 12, and 15. According to this chemical reaction, the LOXs are named 5-, 12-, and 15-LOX, amongst which, 15-LOX with isoforms 15-LOX-1 and 15-LOX-2 have critical role in neoplastic diseases. 15-LOX-1 is overexpressed in some neoplastic conditions. Hence, in this research, we focused on the synthesis of naphthalimide analogs as potential 15-LOX-1 inhibitors. Fortunately, the most of synthesized compounds demonstrated remarkable inhibitory potency towards 15-LOX-1 in nanomolar ranges. Naphthalimide derivatives could be suggested as potential LOX inhibitors with likely applications of anticancer activity.


Keywords


Synthesis; Lipoxygense; Naphthalimide; Arachidonic acid

Full Text:

PDF

References


Matsuyama M, Yoshimura R. Relationship between arachidonic acid pathway and human renal cell carcinoma. Onco Targets Ther. 2008;1:41-48.

Rioux N, Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis. 1998;19(8):1393-1400.

Tong WG, Ding XZ, Adrian TE. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun. 2002;296(4):942-948.

Shi HY, Lv FJ, Zhu ST, Wang QG, Zhang ST. Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma. Cancer Lett. 2011;309(1): 19-26.

Kenyon V, Chorny I, Carvajal WJ, Holman TR, Jacobson MP. Novel human lipoxygenase inhibitors discovered using virtual screening with homology models. J Med Chem. 2006;49(4):1356-1363.

Steele VE, Holmes CV, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, et al. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev. 1999;8(5):467-483.

Shureiqi I, Chen D, Jack Lee J, Yang P, Newman RA, Brenner DE, et al. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-Induced apoptosis in colorectal cancer cells. J Natl Cancer Inst. 2000;92(14):1136-1142.

Shureiqi I, Lippman SM: Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 2001;61(17):6307-6312.

Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis. 2001;22(11): 1765-1773.

Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, et al. Nonsteroidal anti-Inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-Lipoxygenase-1 expression. Cancer Res. 2001;61(12):4879-4884.

Mahdavi M, Shirazi MS, Taherkhani R, Saeedi M, Alipour E, Moghadam FH, et al. Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors. Eur J Med Chem. 2014;82:308-313.

Milelli A, Tumiatti V, Micco M, Rosini M, Zuccari G, Raffaghello L, et al. Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents. Eur J Med Chem. 2012;57:417-428.

Yang L, Li W, Tian Z, Zhao J, Wang C. Mononaphthalimide spermidine conjugate induces cell proliferation inhibition and apoptosis in HeLa cells. Toxicol in Vitro. 2011;25(4):882-889.

Wu A, Xu Y, Qian X. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: Design, synthesis and potential antitumor activity. Bioorg Med Chem. 2009;17(2):592-599.

Wu A, Xu Y, Qian X, Wang J, Liu J. Novel naphthalimide derivatives as potential apoptosis-inducing agents: Design, synthesis and biological evaluation. Eur J Med Chem. 2009;44(11):4674-4680.

Wang K, Wang Y, Yan X, Chen H, Ma G, Zhang P, et al. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths. Bioorg Med Chem Lett. 2012;22(2):937-941.

Li S, Xu S, Tang Y, Ding S, Zhang J, Wang S, et al. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives. Bioorg Med Chem Lett. 2014;24(2):586-590.

Wang X, Chen Z, Tong L, Tan S, Zhou W, Peng T, et al. Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). Eur J Med Chem. 2013;65:477-486.

Lia X, Lina Y, Yuana Y, Liua K, Qiana X. Novel efficient anticancer agents and DNA-intercalators of 1,2,3-triazol-1,8-naphthalimides: design, synthesis, and biological activity. Tetrahedron. 2011; 67(12):2299-2304.

Sk UH, Prakasha Gowda AS, Crampsie MA, Yun JK, Spratt TE, Amin S, et al. Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics. Eur J Med Chem. 2011;46(8):3331-3338.

Mohammadi-Farani A, Ahmadi A, Nadri H, Aliabadi A. Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione with potential anti-alzheimer effects. Daru. 2013;21(1):47.

Agamennone M, Campestre C, Preziuso S, Consalvi V, Crucianelli M, Mazza F, et al. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2. Eur J Med Chem. 2005;40(3):271-279.

Mohammadi-Farani A, Foroumadi A, Rezvani Kashani M, Aliabadi A. N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Synthesis and cytotoxicity evaluation as anticancer agents. Iran J Basic Med Sci. 2014;17(7):502-508.

Anthon GE, Barrett DM. Colorimetric method for the determination of lipoxygenase activity. J Agric Food Chem. 2001;49(1):32-37.

Sadeghian H, Attaran N, Jafari Z, Saberi MR, Seyedi SM, Eshghi H, et al. Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them. Bioorg Med Chem. 2009;17(6):2327-2335.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.